Physiological Basis of Cardiovascular Protection by SGLT2 Inhibitors in Diabetic Ischemic Heart Disease. Cuestiones de Fisioterapia, [S. l.], v. 53, n. 03, p. 7105–7113, 2024. DOI: 10.48047/60np5h83. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/4002.. Acesso em: 14 apr. 2026.